Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?

Hims & Hers Health may only generate a fraction of its competitors revenue, but its fiscal management and exponential growth point to a very bright future.

MarketBeat · Nov 19, 2025

End the Year Strong With These 3 Comeback Champions

Delta Air Lines, Diamondback Energy, and HEICO could all benefit from internal and external drivers of momentum heading into the end of the year.

MarketBeat · Nov 19, 2025

Down 45% Year-to-Date, Novo Nordisk Ignites a Price War

Novo Nordisk's new pricing for its GLP-1 drugs is a strategic pivot to capture a mass market, pressure rivals, and secure long-term market dominance.

MarketBeat · Nov 19, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Institutions Love These 3 Companies, Should You As Well?

Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional investors.

MarketBeat · Nov 19, 2025

3 Data Center Stocks Are Soaring—Analysts Think 1 Could Go Higher

As many data center stocks soar, see where Wall Street analysts are showing trepidation and where they are favoring the potential for upside.

MarketBeat · Nov 19, 2025

Why GRAIL Stock Could Be Biotech’s Next Big Breakout

Explore insider buying signals, a promising cancer detection biotech, and why the American Dream is still achievable—even in a down market.

MarketBeat · Nov 19, 2025

Why Ford's Deal With Amazon Is Bigger Than You Think

Ford's Amazon partnership for used cars marks a monumental shift, creating a capital-efficient retail model that leverages its vast dealer network.

MarketBeat · Nov 19, 2025

Read news from The Economist, FT, and more,
with one subscription

Buyer Beware: Carvana Is Driving an Auto Lending Crisis

Carvana has posted enormous gains over the past two years, but its questionable lending practices and underlying financials warrant some concern.

MarketBeat · Nov 19, 2025

Healthcare Rotation Underway: 3 Stocks Leading the Charge

Are healthcare stocks finally back in fashion? After years of underperformance, a healthcare rotation is underway, led by these three innovative drug makers.

MarketBeat · Nov 19, 2025

Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum

Medtronic is on track to advance in 2026 and could rise by 20% to 30% before year-end. Analysts and institutions are accumulating in 2025.

MarketBeat · Nov 19, 2025

Why Intuitive Machines Is Taking Off While Broader Market Sinks

Intuitive Machines stock is surging despite a weak market. A new acquisition, bullish analyst sentiment, and insider buying point to long-term growth potential

MarketBeat · Nov 19, 2025

What’s on the Thanksgiving Table? A Stock Pick for Every Course

Seaboard, Campbell’s, General Mills, McCormick, and Constellation Brands match every Thanksgiving course—with stocks that could rise this season.

MarketBeat · Nov 18, 2025

Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain

Home Depot's Q4 2025 price pullback is a great time to load up on this buy-and-hold stock. The stage is set for a 2026 rebound.

MarketBeat · Nov 18, 2025

Qualcomm’s Bulls Are Running Out of Room to Be Wrong

Qualcomm’s 20% drop means the bulls have given up all their post-earnings gains, and are once again on the backfoot defending a key support line.

MarketBeat · Nov 18, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat · Nov 18, 2025

Amazon Just Did This—and It Didn't End Well Last Time

Amazon’s RSI crash mirrors last year's setup that preceded a 35% drop. But strong fundamentals would make any dip a major buy this time around.

MarketBeat · Nov 18, 2025

Merck Writes a $9.2 Billion Check for a Flu Drug That Could Change Everything

Merck's multi-billion-dollar acquisition of Cidara Therapeutics is a strategic move to secure a new era of growth with a high-potential antiviral asset.

MarketBeat · Nov 18, 2025

Stellantis Makes a High-Stakes Bet on Jeep

A product-led revival of the iconic Jeep brand is driving Stellantis's North American recovery, signaling an opportunity for investors.

MarketBeat · Nov 18, 2025

Nuclear Energy Earnings: Which Names Won and Lost in Q3

Several key nuclear stocks recently reported Q3 earnings. See how markets reacted to the results of NuScale Power, Constellation Energy, and Oklo.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat · Nov 18, 2025

Alphabet: Buffett's Bet on Its Next Phase of Growth

Berkshire's nearly $5 billion position in GOOGL marks a rare Buffett move into high-growth tech, signaling confidence in the company’s next phase of expansion.

MarketBeat · Nov 18, 2025

Why a 20-Second Flight Test Could Unlock Billions for Vertical

Vertical's transition flight is key to its capital-efficient OEM model, a strategy designed for a faster, more profitable path to market leadership.

MarketBeat · Nov 18, 2025

3 Smart Defensive Stocks for an Uneasy Market

Recession risks persist despite record market highs. Here are three defensive stocks—including PG, JNJ, and the DIA ETF—that can help protect your portfolio

MarketBeat · Nov 18, 2025

These 3 Stocks Are Using Buybacks to Signal Market Confidence

Buybacks are getting a boost at three $20B to $200B firms. Does Trade Desk's repurchase authorization signal confidence, or is it too early to tell?

MarketBeat · Nov 18, 2025

3 Companies to Watch as Natural Gas Stocks Make a Comeback

Natural gas prices are surging. Here are three natural gas stocks that are well-positioned to benefit from rising demand into 2026

MarketBeat · Nov 18, 2025

Seagate Stock Could Soar as AI Drives Storage Demand

Seagate Technology is on the cusp of a value-building revenue and earnings surge. Analysts and institutional trends point to significant gains in 2026.

MarketBeat · Nov 17, 2025

Whirlpool’s Worst May Be Over—Upside Opportunity Ahead

Whirlpool's dividend, value, and outlook make it a good buy; the technical situation, institutional, insider, and analysts trends limit the risk.

1 … 141 142 143 144

Coverage From

MarketBeat

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.